Gyre Therapeutics's market cap is currently $678.48M. The company's EPS TTM is $0; its P/E ratio is 458.28; Gyre Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.
